Steelhead Partners »

Bridgebio Pharma shares owned by Steelhead Partners

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Steelhead Partners from 13F filings

Historical chart of Steelhead Partners investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Steelhead Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Steelhead Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $30B 30M 988.34
2025-06-30 $13B 14M 937.98

More positions owned by Steelhead Partners

Halo 0 1/4 03/01/27 Note 0.250% 3/0 (Principal)
Itri 0 03/15/26 Note 3/1 (Principal)
Aeis 2 1/2 09/15/28 Note 2.500% 9/1 (Principal)
Uber 0 12/15/25 Note 12/1 (Principal)
BL 1 06/01/29 Note 1.000% 6/0 (Principal)
Alrm 2 1/4 06/01/29 Note 2.250% 6/0 (Principal)
Uber 0 7/8 12/01/28 Note 0.875%12/0 (Principal)
DXCM 0 3/8 05/15/28 Note 0.375% 5/1 (Principal)
Spot 0 03/15/26 Note 3/1 (Principal)
Sealtd 0 1/4 09/15/26 Note 0.250% 9/1 (Principal)
Box 0 01/15/26 Note 1/1 (Principal)
Akam 1 1/8 02/15/29 Note 1.125% 2/1 (Principal)
Akam 0 3/8 09/01/27 Note 0.375% 9/0 (Principal)
Net 0 08/15/26 Note 8/1 (Principal)
Jazz 2 06/15/26 Note 2.000% 6/1 (Principal)

View all positions for Steelhead Partners

Top funds holding Bridgebio Pharma

Linden Advisors
Wolverine Asset Management
Camden Asset Management
Sona Asset Management
Ing Investment Management
Steelhead Partners
Davidson Kempner Capital Management
MacKay Shields
D. E. Shaw & Co
Jump Financial
Wells Fargo & Company
Advent Capital Management
Laurion Capital Management
State Street Corporation
Lazard Asset Management

View all funds holding Bridgebio Pharma